Building strategic partnerships to advance clinical excellence - our recent collaboration with Sharehereon Health has opened doors to high-quality refractory cancer care at Parkway Shanghai Hospital.
On 1 November, Parkway Shanghai Hospital partnered Professor Ding Gang, Founder of Sharehereon Health, to launch the Parkway Shanghai Hospital Oncology Center and Parkway International Refractory Oncology Consultation Center. This strategic collaboration unifies the expertise and resources of both healthcare organisations to deliver better oncology diagnosis and treatment for cancer patients.
“This strategic partnership is a harbinger of more great things to come. Refractory cancer, which is the cancer resistant to standard treatment, is a high potential segment in the private healthcare space and there’s great promise in it cementing our domain expertise in oncology,” shared Dr Prem Kumar Nair, Group CEO of IHH Healthcare, during his opening address.
Buoyed by this new development, IHH China will continue to innovate clinical practices, foster multidisciplinary cooperation and prioritise holistic patient care, to bring hope and improved outcomes to more cancer patients in Shanghai.
Related Stories
Gleneagles MediCentre Opens in Hong Kong, Redefining Smart and Seamless Care
Step inside a new era of connected, technology-enabled care designed around patients’ needs.
.png?sfvrsn=3ba27871_1)
Celebrating the D.N.A. of Excellence across IHH Labs
The recent IHH Labs Townhall was especially meaningful as we celebrated the achievements of our medical technologists - the very backbone of IHH Laboratories - through the launch of the Global IHH Labs D.N.A. Award, which stands for Discovery, Nurturing, and Accuracy.
IHH Healthcare Shines at The Economic Times Healthcare Awards 2025
Explore the award-winning care and innovation across our network.
Gleneagles Hospital Chennai Propels the Frontier of Advanced Cancer Care and Robotic Oncology
On 27 September, over 300 delegates converge to exchange knowledge and deliberate on advanced cancer surgery, robotic oncology, head and neck oncology, radiation therapy, and supportive care.
Gleneagles JPMC Partners Ministry of Health Brunei in Nation-wide Fight Against Non-communicable Diseases
Gleneagles JPMC is reinforcing its commitment to world-class cardiac care as part of Brunei’s whole-of-nation effort to combat non-communicable diseases.
